missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Procollagen I N-Peptide Polyclonal Antibody

Description
This antibody is predicted to react with most mammals, birds, amphibians and fish based on 100% sequence homology. This antibody contains enough material to conduct 10 mini-Western blots.
Procollagen type I N-terminal propeptide (P1NP) is a specific marker of bone formation, reflecting the synthesis of type I collagen, which constitutes the major part of the bone matrix. P1NP is derived during the conversion of procollagen to collagen, produced by osteoblasts during bone formation. Its primary clinical application lies in the diagnosis and monitoring of metabolic bone diseases, particularly osteoporosis. In osteoporotic patients, P1NP levels can predict bone mineral density (BMD) responses to treatments like teriparatide and romosozumab. Low serum levels of P1NP are indicative of a high risk of BMD loss, providing a valuable tool for premenopausal women with systemic lupus erythematosus (SLE) and other conditions affecting bone health.
Specifications
Specifications
| Antigen | Procollagen I N-Peptide |
| Applications | Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.15 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative; pH 7.5 |
| Gene | COL1A1 |
| Gene Accession No. | P02452, P02454, P11087 |
| Gene Alias | P1NP; Procollagen I N |
| Gene Symbols | COL1A1 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?